Co-variation of neuropeptide Y, calcitonin gene-related peptide, substance P and neurokinin A in joint fluid from patients with temporomandibular joint arthritis.
Forty-one patients (37 female and four male) with signs and symptoms of temporomandibular joint arthritis, were separated into two diagnostic groups (group I: inflammatory; group II: degenerative/non-specific joint disease). They were examined clinically, fluid was aspirated from the joint with saline and venous blood samples were collected at the same time. The joint fluid and plasma samples were analysed for neuropeptide-like immunoreactivity, i.e. neuropeptide Y (NPY-LI), calcitonin gene-related peptide (CGRP-LI), substance P (SP-LI) and neurokinin A (NKA-LI), using competitive radioimmunoassays. The aim was to investigate any co-variation of the peptides in the joint fluid and plasma. In group I, the median values of peptide concentrations in joint fluid were SP-LI = 129, CGRP-LI = 75, NKA-LI = 36 and NPY-LI = 676 pmol/l and in group II, SP-LI = 52, CGRP-LI = 64, NKA-LI = 45 and NPY-LI = 318 pmol/l. There were no significant differences between the groups for peptide concentrations. In group I, all the neuropeptides were strongly correlated. In group II, SP-LI and NKA-LI were strongly correlated while CGRP-LI was weakly correlated with NPY-LI and NKA-LI. Multiple step-wise regression analysis showed that most of the variation in NPY-LI, CGRP-LI and SP-LI in group I was explained by NKA-LI, but the regression did not reach statistical significance in group II.
Alstergren
P
P
Department of Clinical Oral Science, Karolinska Institutet, Huddinge, Sweden.
Appelgren
A
A
Appelgren
B
B
Kopp
S
S
Lundeberg
T
T
Theodorsson
E
E
D000328:Adult; D000368:Aged; D001168:Arthritis / Q000097:blood / Q000378:metabolism*; D015535:Arthritis, Psoriatic / Q000378:metabolism; D001172:Arthritis, Rheumatoid / Q000378:metabolism; D015740:Calcitonin Gene-Related Peptide / Q000032:analysis* / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015288:Neurokinin A / Q000032:analysis* / Q000097:blood; D009478:Neuropeptide Y / Q000032:analysis* / Q000097:blood; D010003:Osteoarthritis / Q000378:metabolism; D012044:Regression Analysis; D013167:Spondylitis, Ankylosing / Q000378:metabolism; D013373:Substance P / Q000032:analysis* / Q000097:blood; D013582:Synovial Fluid / Q000737:chemistry*; D013705:Temporomandibular Joint Disorders / Q000097:blood / Q000378:metabolism*
D009478:Neuropeptide Y; D013373:Substance P; D015288:Neurokinin A; D015740:Calcitonin Gene-Related Peptide